Court Square Group

We love our community in Springfield-- Tap into TechSpring is here again tomorrow! Join us at TechSpring - The Baystate Health Technology Innovation Center "the vibrant innovation community of technologists and healthcare professionals working together to solve the very real challenges in healthcare today. We do this over food, beer, and good cheer."

August's Tap into TechSpring 1350 MAIN STREET, 5TH FLOOR, SPRINGFIELD, MA 01103 USA

Join Court Square Group and the largest, most engaged community for regulatory professionals, in-person, at the 2018 RAPS Regulatory Convergence conference coming up in October. See you at booth #302!

2018 RAPS Regulatory Convergence Join RegDocs365 and Court Square Group, Inc. at the RAPS Regulatory Convergence Conference Vancouver Convention Centre East   October 1-4 2018 Booth: #302

As technology regulations and requirements evolve and into a sustainable infrastructure for data management and organization, our standards tone themselves. We enable our clients to show control over their in environments so that they are always audit-ready.
"IDMP (identification of medical products) regulation supports EU terminology for products, substances, and organizations in order to power pharmacovigilance and systems.
In this, they hope to improve safety signal detection and response, verify authenticity, address shortages and recalls quickly, and increase regulatory efficiency...
This transition is part of a two-year rollout with adoption mandatory by 2018."

Regulatory Changes on the Horizon: Global Impact of the IDMP | Glemser Technologies Corporation Regulatory Changes on the Horizon: Global Impact of the IDMP Posted: July 6, 2016July 6, 2016  by Raymond Glemser Categories: Industry Views Share Pharmaceutical manufacturers and CROs face increasingly complex regulatory mandates on the horizon. As requirements increase, so do opportunities for pr...

Everyone wants to know how to create a successful plan that moves their solution from a vague idea to a solid reality, and in the process create true transformational change in healthcare. Don't forget to register for TapIn! Tap into TechSpring - The Baystate Health Technology Innovation Center this Thursday!

July's Tap into TechSpring: Employees on FIRE! How Innovation Programming Ignites Transformation 1350 MAIN STREET, 5TH FLOOR, SPRINGFIELD, MA 01103 USA

DrugInfoAssn Annual Boston conference is still on! Join RegDocs365 and Court Square Group, along with thousands of innovators from around the world to gather in Boston-- conference ends Thursday, June 28!

Find us and explore the opportunities that RegDocs365 and Court Square Group offer to enhance your Qualified Hosting and Validation services.
BOSTON CONVENTION AND EXHIBITION CENTER:
415 SUMMER ST, BOSTON, MA 02210
BOOTH #2213

Repost from: DrugInfoAssn: This article (written by Sandra Blumenrath) summarizes key takeaways from sessions in “Topic F: What Can Stakeholders Expect from Clinical Trial (Development), Transparency, and Medical Information?" Merete Jorgenson shares her feedback on the advancing requirements that accompany the primary challenge of data security.
"Research participants drive medical product development. Without an ability to gain the trust of patients and effectively recruit research participants, there will be no clinical trials and no new medicines."

Clinical Trial Development, Transparency, and Medical Information: Gaining the Trust of Patients Data transparency in clinical trials is key. Allowing for public scrutiny, for example, establishes trust and confidence in clinical trials among patients.

Recently Court Square Group was highlighted by CIOApplications.com for bringing key solutions to the Life-Science industry. In this article, you will see that the Challenge for many of our clients centralizes around maintaining Qualified and Validated environments.
Hear from Keith Parent (founder, CEO) about our proven solutions in his interview with CIOApplications here.

Court Square Group: Enabling Seamless Compliance

Court Square Group is gearing up once again for the DrugInfoAssn Global Annual meeting in Boston; Here are 8 great reasons to attend and get involved!

engage.diaglobal.org

Since the first pharma-backed internet trials took place in 2001, there have been waves of efforts to optimize the virtual trial experience… Here's an update.

Nature Article Reviews: Industry Embraces Virtual Trial Platforms In a recent post by  Nature Reviews Drug Discovery  titled  Industry Embraces Virtual Trial Platforms,  author Elie Dolgin steps onto the virtual platform herself to deliver new facts on virtual clinical trials with mentions of a few familiar friends of Court Squa

Court Square in action: Today Keith and Mary are in Miami- locked in the morning session of One-on-One Meetings at the Evolution Summit sharing the vision and value of Court Square.

meSummitsPharma on Twitter

Many of our clients are at the forefront of developing life-changing medicines for the future... This week we want to highlight BluebirdBio for their success with the new drug, LentiGlobin in treating TDT (Transfusion-Dependent β-Thalassemia) through gene therapy.
Individuals who have the genetic mutation causing TDT must undergo consistent blood transfusions to cope with the disease.
In this trial, observations stretch a two-year timeframe-- the collected data shows that the patients with TDT “were able to maintain independence from transfusion without unexpected or unmanageable side effects,” said Dr. Alexis Thompson, Head of Hematology and Director of the Comprehensive Thalassemia Program at Ann & Robert H. Lurie Children’s Hospital of Chicago, and Professor of Pediatrics at Northwestern University Feinberg School of Medicine and one of the lead authors of the NEJM paper.
She continued in her statement to the New England Journal of Medicine that, “These results suggest that gene therapy could become an effective treatment for TDT.”

Gene Therapy Looks Promising for Transfusion-Dependent β-Thalassemia